Branka Radic-Sarikas

Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy

K. Huber, E. Salah, Branka Radic-Sarikas et al. · Nature · 2014 · 387 citations · Full text

Medicinal Chemistry, Drug Targeting, Anticancer Strategy +9

The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

Georg E. Winter, Branka Radic-Sarikas, Cristina Mayor‐Ruiz et al. · Nature Chemical Biology · 2014 · 182 citations · Full text

Genome Instability, Natural Sciences, Dna Replication +3

Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions

Rui Martins, Julia Maier, Anna-Dorothea Gorki et al. · Nature Immunology · 2016 · 141 citations

Microbial Pathogens, Pathogenesis, Immunology +10

YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells

Lisa Bierbaumer, Anna M. Katschnig, Branka Radic-Sarikas et al. · Oncogenesis · 2021 · 57 citations · Full text

Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter

Branka Radic-Sarikas, Melinda Halász, K. Huber et al. · Scientific Reports · 2017 · 33 citations · Full text